journal
https://read.qxmd.com/read/38635186/macrophages-and-natural-killers-degrade-%C3%AE-synuclein-aggregates
#1
JOURNAL ARTICLE
Mikhail Matveyenka, Kiryl Zhaliazka, Dmitry Kurouski
Amyloid oligomers and fibrils are protein aggregates that exert a high cell toxicity. Efficient degradation of these protein aggregates can minimize the spread and progression of neurodegeneration. In this study, we investigate the properties of natural killer (NK) cells and macrophages in the degradation of α-synuclein (α-Syn) aggregates grown in a lipid-free environment and in the presence of phosphatidylserine and cholesterol (PS/Cho), which are lipids that are directly associated with the onset and progression of Parkinson's disease...
April 18, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38630656/recent-progress-of-small-interfering-rna-delivery-on-the-market-and-clinical-stage
#2
REVIEW
Fan Guo, Yan Li, Wenjun Yu, Yuanlei Fu, Jing Zhang, Haiqiang Cao
Small interfering RNAs (siRNAs) are promising therapeutic strategies, and five siRNA drugs have been approved by the Food and Drug Administration (FDA) and the European Commission (EC). This marks a significant milestone in the development of siRNA for clinical applications. The approved siRNA agents can effectively deliver siRNAs to the liver and treat liver-related diseases. Currently, researchers have developed diverse delivery platforms for transporting siRNAs to different tissues such as the brain, lung, muscle, and others, and a large number of siRNA drugs are undergoing clinical trials...
April 17, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38629958/voices-in-molecular-pharmaceutics-meet-professor-keisuke-ueda-who-scrutinizes-the-molecular-level-properties-of-drugs-and-formulations-using-nmr-spectroscopy
#3
EDITORIAL
https://read.qxmd.com/read/38626389/feasibility-study-of-single-photon-emission-computed-tomography-with-iodine-123-labeled-metaiodobenzylguanidine-for-preclinical-evaluation-of-labetalol-as-a-%C3%AE-adrenergic-receptor-blocker
#4
JOURNAL ARTICLE
Yiseul Choi, Eun Sang Lee, Sang-Keun Woo, Kyo Chul Lee, Hye Kyung Chung, Joo Hyun Kang
Among clinically used radiopharmaceuticals, iodine-123 labeled metaiodobenzylguanidine ([123 I]mIBG) serves for diagnosing neuroendocrine tumors and obtaining images of myocardial sympathetic innervation. mIBG, a structural analogue of norepinephrine (NE), a neurotransmitter acting in peripheral and central nerves, follows a pathway similar to NE, transmitting signals through the NE transporter (NET) located at synaptic terminals. It moves through the body without decomposing, enabling noninvasive image evaluation...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38625037/transfer-of-ans-like-drugs-from-micellar-drug-delivery-systems-to-albumin-is-highly-favorable-and-protected-from-competition-with-surfactant-by-reserved-binding-sites
#5
JOURNAL ARTICLE
Iulia Carabadjac, Leonie C Vormittag, Thomas Muszer, Jakob Wuth, Maximilian H Ulbrich, Heiko Heerklotz
Micellar drug delivery systems (MDDS) for the intravenous administration of poorly soluble drugs have great advantages over alternative formulations in terms of the safety of their excipients, storage stability, and straightforward production. A classic example is mixed micelles of glycocholate (GC) and lecithin, both endogenous substances in human blood. What limits the use of MDDS is the complexity of the transitions after injection. In particular, as the MDDS disintegrate partially or completely after injection, the drug has to be transferred safely to endogenous carriers in the blood, such as human serum albumin (HSA)...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38625027/insulin-signaling-differentially-regulates-the-trafficking-of-insulin-and-amyloid-beta-peptides-at-the-blood-brain-barrier
#6
JOURNAL ARTICLE
Andrew L Zhou, Suresh K Swaminathan, Vrishali S Salian, Lushan Wang, Geoffry L Curran, Hoon-Ki Min, Val J Lowe, Karunya K Kandimalla
The blood-brain barrier (BBB) is instrumental in clearing toxic metabolites from the brain, such as amyloid-β (Aβ) peptides, and in delivering essential nutrients to the brain, like insulin. In Alzheimer's disease (AD) brain, increased Aβ levels are paralleled by decreased insulin levels, which are accompanied by insulin signaling deficits at the BBB. Thus, we investigated the impact of insulin-like growth factor and insulin receptor (IGF1R and IR) signaling on Aβ and insulin trafficking at the BBB...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38623055/customizable-porphyrin-platform-enables-folate-receptor-pet-imaging-using-copper-64
#7
JOURNAL ARTICLE
Hailey A Houson, Zhiyuan Wu, Phuong-Lien Doan Cao, Jonathan S Lindsey, Suzanne E Lapi
Folate receptors including folate receptor α (FRα) are overexpressed in up to 90% of ovarian cancers. Ovarian cancers overexpressing FRα often exhibit high degrees of drug resistance and poor outcomes. A porphyrin chassis has been developed that is readily customizable according to the desired targeting properties. Thus, compound O5 includes a free base porphyrin, two water-solubilizing groups that project above and below the macrocycle plane, and a folate targeting moiety. Compound O5 was synthesized (>95% purity) and exhibited aqueous solubility of at least 0...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38622497/lipids-extracted-from-mycobacterial-membrane-and-enveloped-plga-nanoparticles-for-encapsulating-antibacterial-drugs-elicit-synergistic-antimicrobial-response-against-mycobacteria
#8
JOURNAL ARTICLE
Xueyu Pu, Yuanyuan Wang, Xi Wang, Xiaoqing Sang, Miaomiao Jiang, DaWei Qi, Xin Zhao, Rong Chen, Jianwei Li, Xiang Liu, Zhidong Liu, Jian Yang
Tuberculosis (TB) is a chronic disease caused by Mycobacterium tuberculosis (Mtb), which shows a long treatment cycle often leads to drug resistance, making treatment more difficult. Immunogens present in the pathogen's cell membrane can stimulate endogenous immune responses. Therefore, an effective lipid-based vaccine or drug delivery vehicle formulated from the pathogen's cell membrane can improve treatment outcomes. Herein, we extracted and characterized lipids from Mycobacterium smegmatis , and the extracts contained lipids belonging to numerous lipid classes and compounds typically found associated with mycobacteria...
April 15, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38620059/blue-light-activated-water-soluble-sn-iv-porphyrins-for-antibacterial-photodynamic-therapy-apdt-against-drug-resistant-bacterial-pathogens
#9
JOURNAL ARTICLE
T Nagarajan, M P Gayathri, John Mack, Tebello Nyokong, Sutharsan Govindarajan, Balaji Babu
Antimicrobial resistance has emerged as a global threat to the treatment of infectious diseases. Antibacterial photodynamic therapy (aPDT) is a promising alternative approach and is highly suitable for the treatment of cutaneous bacterial infections through topical applications. aPDT relies on light-responsive compounds called photosensitizer (PS) dyes, which generate reactive oxygen species (ROS) when induced by light, thereby killing bacterial cells. Despite several previous studies in this area, the molecular details of targeting and cell death mediated by PS dyes are poorly understood...
April 15, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38607681/phospholipid-type-regulates-protein-corona-composition-and-in-vivo-performance-of-lipid-nanodiscs
#10
JOURNAL ARTICLE
Feng Pan, Mengyuan Liu, Guanghui Li, Boqian Chen, Yuxiu Chu, Yang Yang, Ercan Wu, Yifei Yu, Shiqi Lin, Tianhao Ding, Xiaoli Wei, Changyou Zhan, Jun Qian
Over the years, there has been significant interest in PEGylated lipid-based nanocarriers within the drug delivery field. The inevitable interplay between the nanocarriers and plasma protein plays a pivotal role in their in vivo biological fate. Understanding the factors influencing lipid-based nanocarrier and protein corona interactions is of paramount importance in the design and clinical translation of these nanocarriers. Herein, discoid-shaped lipid nanodiscs (sNDs) composed of different phospholipids with varied lipid tails and head groups were fabricated...
April 12, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38606716/design-synthesis-and-evaluation-of-18-f-bibd-300-as-a-positron-emission-tomography-tracer-for-poly-adp-ribose-polymerase-1
#11
JOURNAL ARTICLE
Wei Zheng, Yong Huang, Yi Xie, Tingyu Yang, Xuebo Cheng, Hualong Chen, Chengze Li, Zeng Jiang, Ziyue Yu, Zhongjing Li, Lu Zhang, Leilei Yuan, Yajing Liu, Ying Liang, Zehui Wu
Compounds 8a - j were designed to adjust the mode of interaction and lipophilicity of FTT by scaffold hopping and changing the length of the alkoxy groups. Compounds 8a , 8d , 8g , and BIBD-300 were screened for high-affinity PARP-1 through enzyme inhibition assays and are worthy of further evaluation. PET imaging of MCF-7 subcutaneous tumors with moderate expression of PARP-1 showed that compared to [18 F]FTT, [ 18 F]8a , [ 18 F]8d , and [ 18 F]8g exhibited greater nonspecific uptake, a lower target-to-nontarget ratio, and severe defluorination, while [18 F]BIBD-300 exhibited lower nonspecific uptake and a greater target-to-nontarget ratio...
April 12, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38606663/synthesis-screening-and-evaluation-of-theranostic-molecular-cpcr4-based-probe-targeting-cxcr4
#12
JOURNAL ARTICLE
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Chemokines and chemokine receptors are indispensable to play a key role in the development of malignant tumors. As one of the most widely expressed chemokine receptors, chemokine (C-X-C motif) receptor 4 (CXCR4) has been a popular research focus. In most tumors, CXCR4 expression is significantly upregulated. Moreover, integrated nuclide diagnosis and therapy targeting CXCR4 show great potential. [68 Ga]Ga-pentixafor, a radioligand targeting CXCR4, exhibits a strong affinity for CXCR4 both in vivo and in vitro...
April 12, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38602861/transdermal-delivery-of-pramipexole-using-microneedle-technology-for-the-potential-treatment-of-parkinson-s-disease
#13
JOURNAL ARTICLE
Mary B McGuckin, Aaron R J Hutton, Ellie R Davis, Akmal H B Sabri, Anastasia Ripolin, Achmad Himawan, Yara A Naser, Rand Ghanma, Brett Greer, Helen O McCarthy, Alejandro J Paredes, Eneko Larrañeta, Ryan F Donnelly
Parkinson's disease (PD) is a debilitating neurodegenerative disease primarily impacting neurons responsible for dopamine production within the brain. Pramipexole (PRA) is a dopamine agonist that is currently available in tablet form. However, individuals with PD commonly encounter difficulties with swallowing and gastrointestinal motility, making oral formulations less preferable. Microneedle (MN) patches represent innovative transdermal drug delivery devices capable of enhancing skin permeability through the creation of microconduits on the surface of the skin...
April 11, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38600804/physiologically-based-biopharmaceutics-modeling-pbbm-best-practices-for-drug-product-quality-regulatory-and-industry-perspectives-2023-workshop-summary-report
#14
REVIEW
Claire Mackie, Sumit Arora, Paul Seo, Rebecca Moody, Bhagwant Rege, Xavier Pepin, Tycho Heimbach, Christer Tannergren, Amitava Mitra, Sandra Suarez-Sharp, Luiza Novaes Borges, Shinichi Kijima, Evangelos Kotzagiorgis, Maria Malamatari, Shereeni Veerasingham, James E Polli, Gregory Rullo
Physiologically based biopharmaceutics modeling (PBBM) is used to elevate drug product quality by providing a more accurate and holistic understanding of how drugs interact with the human body. These models are based on the integration of physiological, pharmacological, and pharmaceutical data to simulate and predict drug behavior in vivo. Effective utilization of PBBM requires a consistent approach to model development, verification, validation, and application. Currently, only one country has a draft guidance document for PBBM, whereas other major regulatory authorities have had limited experience with the review of PBBM...
April 10, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38588328/enhanced-theranostic-efficacy-of-89-zr-and-177-lu-labeled-aflibercept-in-renal-cancer-a-viable-option-for-clinical-practice
#15
JOURNAL ARTICLE
Zhao Chen, Qi Yang, Lele Song, Yongkang Qiu, Tianyao Wang, Sitong Wu, Wenpeng Huang, Xinyao Sun, Aixiang Wang, Lei Kang
Vascular endothelial growth factor (VEGF) targeted therapy serves as an important therapeutic approach for renal cancer, but its clinical effectiveness is unsatisfactory. Moreover, there is a lack of reliable biomarkers for preoperative assessment of tumor VEGF expression. This study aimed to explore the potential for further applications of 177 Lu/89 Zr-labeled aflibercept (Abe), a VEGF-binding agent, in imaging visualization of VEGF expression and therapy for renal cancer. To determine specificity uptake in renal cancer, BALB/c mice with VEGF-expressing Renca tumor were intravenously injected with [89 Zr]Zr-Abe, [177 Lu]Lu-Abe, or Cy5...
April 8, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38579335/quantifying-the-lymphatic-transport-of-model-therapeutics-from-the-brain-in-rats
#16
JOURNAL ARTICLE
Thu A Hoang, Gracia Gracia, Enyuan Cao, Joseph A Nicolazzo, Natalie L Trevaskis
In recent years, the drainage of fluids, immune cells, antigens, fluorescent tracers, and other solutes from the brain has been demonstrated to occur along lymphatic outflow pathways to the deep cervical lymph nodes in the neck. To the best of our knowledge, no studies have evaluated the lymphatic transport of therapeutics from the brain. The objective of this study was to determine the lymphatic transport of model therapeutics of different molecular weights and lipophilicity from the brain using cervical lymph cannulation and ligation models in rats...
April 5, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38576375/the-effect-of-lipid-composition-on-the-liposomal-delivery-of-camptothecin-developed-by-active-click-loading
#17
JOURNAL ARTICLE
Lei Xie, Qian Zhang, Qian Zhu, Yang Wang, Shuijiao Niu, Xinyue Zhang, Yuting Huang, Jiayao Li, Xiaoxue Liu, Zhiyuan Xue, Xia Zhao, Yaxin Zheng
In the present study, we investigated the role of lipid composition of camptothecin (CPT)-loaded liposomes (CPT-Lips) to adjust their residence time, drug distribution, and therefore the toxicities and antitumor activity. The CPT was loaded into liposomes using a click drug loading method, which utilized liposomes preloaded with GSH and then exposed to CPT-maleimide. The method produced CPT-Lips with a high encapsulation efficiency (>95%) and sustained drug release. It is shown that the residence times of CPT-Lips in the body were highly dependent on lipid compositions with an order of non-PEGylated liposomes of unsaturated lipids < non-PEGylated liposomes of saturated lipids < PEGylated liposomes of saturated lipids...
April 5, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38574292/role-for-carboxylic-acid-moiety-in-nsaids-favoring-the-binding-at-site-ii-of-bovine-serum-albumin
#18
JOURNAL ARTICLE
Luiza de Carvalho Bertozo, Hugo Cesar Tadeu, Anila Sebastian, Martyna Maszota-Zieleniak, Sergey A Samsonov, Valdecir Farias Ximenes
The molecular structures of nonsteroidal anti-inflammatory drugs (NSAIDs) vary, but most contain a carboxylic acid functional group (RCOOH). This functional group is known to be related to the mechanism of cyclooxygenase inhibition and also causes side effects, such as gastrointestinal bleeding. This study proposes a new role for RCOOH in NSAIDs: facilitating the interaction at the binding site II of serum albumins. We used bovine serum albumin (BSA) as a model to investigate the interactions with ligands at site II...
April 4, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38573777/synthesis-and-evaluation-of-radiogallium-labeled-bone-imaging-probes-using-oligo-%C3%AE-carboxy-glutamic-acid-peptides-as-carriers-to-bone
#19
JOURNAL ARTICLE
Kazuma Ogawa, Kota Nishizawa, Kenji Mishiro, Nurmaya Effendi, Takeshi Fuchigami, Masayuki Munekane, Hiroshi Wakabayashi, Seigo Kinuya
We investigated the importance of the carboxy group density in bone affinity during the development of peptide-based bone-seeking radiopharmaceuticals and carriers. Oligo-γ-carboxy glutamic acid peptides [(Gla) n ] with higher carboxy group density than oligo-glutamic acid peptides [(Glu) n ] and oligo-aspartic acid peptides [(Asp) n ] were chosen. Using the radiogallium chelator N,N' -bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine- N,N' -diacetic acid (HBED-CC), we synthesized [67 Ga]Ga-HBED-CC-(Gla) n ( n = 1, 2, 5, 8, 11, or 14) with high yields...
April 4, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38572979/concentration-dependent-diffusion-of-monoclonal-antibodies-underlying-mechanisms-of-anomalous-diffusion
#20
JOURNAL ARTICLE
Gaurav Kumar, Arezoo M Ardekani
The development, storage, transport, and subcutaneous delivery of highly concentrated monoclonal antibody formulations pose significant challenges due to the high solution viscosity and low diffusion of the antibody molecules in crowded environments. These issues often stem from the self-associating behavior of the antibody molecules, potentially leading to aggregation. In this work, we used a dissipative particle dynamics-based coarse-grained model to investigate the diffusion behavior of IgG1 antibody molecules in aqueous solutions with 15 and 32 mM NaCl and antibody concentrations ranging from 10 to 400 mg/mL...
April 4, 2024: Molecular Pharmaceutics
journal
journal
40586
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.